Boardroom Alpha
Boardroom Alpha
LBTYA · Current Report (Form 8-K) · Filed May 7, 2026

Liberty Global Ltd — Current Report (Form 8-K)

Form
8-K
Filed
May 7, 2026
Period
May 1, 2026
Ticker
LBTYA
Accession
0001570585-26-000075
Boardroom Alpha · Filing insights

Wyre Finance BV arranged a €2.7B term loan and related facilities (Capex €1.2B, revolving €215M, DSR €235M) with Bank of Nova Scotia as agent.

About Liberty Global Ltd
Market cap
$3.6B
1Y TSR
−6.1%
3Y TSR
+3.4%
Board grade
C-
Sector
Communication Services
CEO
Michael T Fries
Last annual meeting: Jun 23, 2026 · View full Liberty Global Ltd profile →
lbtya-20260501

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
Date of report (Date of earliest event reported): May 1, 2026
 
Liberty Global Ltd.
(Exact Name of Registrant as Specified in Charter)
 
Bermuda 001-35961 98-1750381
(State or other jurisdiction
of incorporation)
 (Commission File Number) (IRS Employer
Identification #)
 
Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda
(Address of Principal Executive Office)
 
+1.303.220.6600
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class A common sharesLBTYANasdaq Global Select Market
Class B common sharesLBTYBNasdaq Global Select Market
Class C common sharesLBTYKNasdaq Global Select Market
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 




Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

On May 1, 2026, Wyre Finance BV (the “Company”) entered into (i) a bank facilities agreement between, among others, the Original Bank Facilities Lenders (as defined therein) (the “Original Bank Facilities Lenders”) and The Bank of Nova Scotia as the bank facilities agent and the security agent (the “Bank Facilities Agreement”), (ii) a common terms agreement between, among others, the Original Bank Facilities Lenders and The Bank of Nova Scotia as the bank facilities agent and the security agent (the “Common Terms Agreement”), (iii) a master definitions agreement between, among others, the Original Bank Facilities Lenders and The Bank of Nova Scotia as the bank facilities agent and the security agent (the “Master Definitions Agreement”) and (iv) an intercreditor agreement between, among others, the Original Bank Facilities Lenders and The Bank of Nova Scotia as the bank facilities agent and the security agent (the “Intercreditor Agreement”).

Wyre Finance BV is an indirect wholly-owned subsidiary of Wyre Holding BV, which is a joint venture between Telenet BV (an indirect wholly-owned subsidiary of Liberty Global Ltd.) and Fluvius System Operator CV. Telenet BV owns 66.8% of the issued share capital of Wyre Holding BV and Fluvius System Operator CV owns 33.2% of the issued share capital of Wyre Holding BV.

Under the terms of the Bank Facilities Agreement, the Original Bank Facilities Lenders have agreed to provide a €2.7 billion ($3.2 billion at the May 1, 2026 exchange rate) term loan facility (the “Term Facility”), a €1.2 billion ($1.4 billion at the May 1, 2026 exchange rate) capex term loan facility (the “Capex Facility”), a €215.0 million ($252.2 million at the May 1, 2026 exchange rate) revolving facility (the “Initial Revolving Facility”) and a €235.0 million ($275.1 million at the May 1, 2026 exchange rate) debt service reserve facility (the “DSR Facility” and, together with the Term Facility, the Capex Facility and the Initial Revolving Facility, the “Facilities”) to the Company.

The Term Facility may be drawn to finance the repayment of certain financial indebtedness of Wyre BV and its subsidiaries (the “Group”), financing a dividend or distribution out of the Group in an amount no greater than €3.0 billion ($3.5 billion at the May 1, 2026 exchange rate) or its equivalent in other currencies, financing or refinancing any capital expenditure, permitted acquisition, investment, joint venture, restructuring, refinancing and reorganization requirements of the Group, financing or refinancing the working capital requirements of the Group and financing or refinancing any fees, costs, expenses, taxes and other amounts incurred in connection with the transactions contemplated by the Bank Facilities Agreement and/or the syndication of the Facilities.

The Capex Facility may be drawn to finance or refinance capital expenditure and permitted acquisitions, financing other related amounts, including any breakage costs, interest, redemption premiums, make-whole costs and other fees, costs, expenses and taxes in connection with the finance documents, any permitted acquisitions and/or the financing or refinancing of any indebtedness of any entity that is the subject of a permitted acquisition and financing or refinancing any fees, costs, expenses, taxes and other amounts incurred in connection with the foregoing.

The Initial Revolving Facility may be drawn to finance the ongoing working capital requirements and the general corporate purposes of the Group.

The DSR Facility may be drawn to finance a shortfall in the amount of funds available to the Company for scheduled payments of interest to its secured creditors.

The final maturity date for the Facilities will be the date falling 84 months from the date of first utilization of the Term Facility (the “Closing Date”).

Subject to certain adjustments which may apply as set out in the Bank Facilities Agreement, loans drawn under the Facilities will bear interest at a rate of EURIBOR plus (i) 2.35% per annum from the date of the Bank Facilities Agreement until the third anniversary of the Closing Date, (ii) 2.50% per annum from but excluding the third anniversary of the Closing Date to and including the fourth anniversary of the Closing Date, (iii) 2.75% per annum from but excluding the fourth anniversary of the Closing Date to and including the fifth anniversary of the Closing Date, (iv) 3.00% from but excluding the fifth anniversary of the Closing Date to and including the sixth anniversary of the Closing Date and (v) 3.25% from but excluding the sixth anniversary of the Closing Date until the final maturity date.

The Common Terms Agreement sets out the common terms and conditions applicable across the financing documents, including the Bank Facilities Agreement, any future authorized credit facilities and related hedging agreements (collectively, the "Authorized Credit Facilities"). The Common Terms Agreement is intended to provide a single, unified framework for



representations and warranties, covenants, events of default, mandatory prepayment provisions and agreed security principles that apply to each Authorized Credit Facility, thereby ensuring consistency of terms across the financing documents.

The Master Definitions Agreement sets out the defined terms and principles of interpretation and construction applicable across the financing documents, including the Bank Facilities Agreement, the Common Terms Agreement, the Intercreditor Agreement and each other finance document entered into in connection with the Authorized Credit Facilities.

The Intercreditor Agreement establishes the intercreditor arrangements governing the relative rights and priorities of the secured creditors, the subordinated creditors and the subordinated intragroup creditors in relation to the secured obligations under the financing documents. Its principal purposes include: (i) regulating the claims of the secured creditors against the subordinated creditors and the rights of priority and enforcement; (ii) regulating the claims of the subordinated intragroup creditors and the subordinated creditors; (iii) regulating the exercise, acceleration and enforcement of rights by the secured creditors; and (iv) setting out the entrenched rights and reserved matters of the secured creditors.

The Bank Facilities Agreement is attached hereto as Exhibit 4.1 and is incorporated herein by reference. The foregoing description of the Bank Facilities Agreement is not complete and is subject to and qualified in its entirety by reference to the full text thereof set forth in Exhibit 4.1.

The Master Definitions Agreement is attached hereto as Exhibit 4.2 and is incorporated herein by reference. The foregoing description of the Master Definitions Agreement is not complete and is subject to and qualified in its entirety by reference to the full text thereof set forth in Exhibit 4.2.

The Common Terms Agreement is attached hereto as Exhibit 4.3 and is incorporated herein by reference. The foregoing description of the Common Terms Agreement is not complete and is subject to and qualified in its entirety by reference to the full text thereof set forth in Exhibit 4.3.

The Intercreditor Agreement is attached hereto as Exhibit 4.4 and is incorporated herein by reference. The foregoing description of the Intercreditor Agreement is not complete and is subject to and qualified in its entirety by reference to the full text thereof set forth in Exhibit 4.4.

Item 9.01 Financial Statements and Exhibits.

(d)     Exhibits.

Exhibit No.Exhibit Name
4.1
4.2
4.3
4.4
101.SCHInline XBRL Taxonomy Extension Schema Document
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document
101.LABInline XBRL Taxonomy Extension Label Linkbase Document
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)



SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 LIBERTY GLOBAL LTD.
  
 By:/s/ RANDY L. LAZZELL
  Randy L. Lazzell
  Vice President
 
Date: May 7, 2026

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Liberty Global Ltd (LBTYA)

Reference

Frequently asked questions

When did Liberty Global Ltd file this 8-K?
Liberty Global Ltd (LBTYA) filed this Current Report (Form 8-K) with the SEC on May 7, 2026. The accession number assigned by EDGAR is 0001570585-26-000075.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Wyre Finance BV arranged a €2.7B term loan and related facilities (Capex €1.2B, revolving €215M, DSR €235M) with Bank of Nova Scotia as agent. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Liberty Global Ltd's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Liberty Global Ltd has filed under CIK 1570585, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer